Genmab | GEN - Ebit





Ebit تغيير تاريخ
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Almirall EUR 71.55M 41.32M 2026-06
Amarin USD -2.26M 564K 2025-12
Amgen USD 3.83B 130M 2026-03
argenx SE USD 493M 99M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Bayer EUR 3.53B 2.42B 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Demant DKK 2.07B 201M 2025-12
Exelixis USD 251.34M 15.43M 2026-03
Fresenius Medical Care EUR 268M 395M 2026-03
Genmab DKK 260M 199M 2025-12
GlaxoSmithKline GBP 2.6B 312M 2026-06
GN Store Nord DKK -68M 638M 2026-03
GRIFOLS EUR 249M 103.11M 2026-03
Hikma Pharmaceutical USD 348M 31M 2025-12
Insmed USD -200.28M 49.43M 2026-03
Lakefront Biotherapeutics EUR -63.7M 844.26M 2026-03
Lonza CHF 673M 54M 2025-06
Merck EUR 1.05B 572M 2026-03
Novartis USD 4.73B 549M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 1.12B 811M 2026-06
UCB EUR 1.29B 571M 2025-12